CD8 þ T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancer

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Manipulation of regulatory T cells and antigen‐specific cytotoxic T lymphocyte‐based tumour immunotherapy

  2015influential reference
• Immunology and Immunotherapy of Head and Neck Cancer.

  2015cited by this paper
• Tumor Endothelium FasL Establishes a Selective Immune Barrier Promoting Tolerance in Tumors

  2014cited by this paper
• Regulatory T‐cell homeostasis: steady‐state maintenance and modulation during inflammation

  2014influential reference
• PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.

  2013influential reference
• Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.

  2013cited by this paper
• Human Papillomavirus Type 16 E6/E7-specific Cytotoxic T Lymphocytes for Adoptive Immunotherapy of HPV-associated Malignancies

  2013cited by this paper
• Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy

  2013cited by this paper
• Effects of Adjuvant Chemoradiotherapy on the Frequency and Function of Regulatory T Cells in Patients with Head and Neck Cancer

  2013cited by this paper
• Investigating the role of human papillomavirus in squamous cell carcinoma of the temporal bone

  2013cited by this paper
• The immunosuppressive tumour network: myeloid‐derived suppressor cells, regulatory T cells and natural killer T cells

  2013cited by this paper
• The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities

  2013cited by this paper
• Epithelial Cell Responses to Infection with Human Papillomavirus

  2012cited by this paper
• Radiochemotherapy fosters a favorable pattern of inflammatory cells in head and neck tumors

  2012cited by this paper
• p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors

  2011cited by this paper
• Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer.

  2010influential reference
• p16INK4a overexpression predicts translational active human papillomavirus infection in tonsillar cancer

  2010cited by this paper
• Sensitive HPV detection in oropharyngeal cancers

  2009cited by this paper
• Cell-Mediated Immune Responses to Human Papillomavirus 16 E6 and E7 Antigens as Measured by Interferon Gamma Enzyme-Linked Immunospot in Women With Cleared or Persistent Human Papillomavirus Infection

  2009cited by this paper
• Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.

  2009cited by this paper
• A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia.

  2007cited by this paper
• Vaccination trial with HPV16 L1E7 chimeric virus‐like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)

  2007cited by this paper
• The E7 Oncoprotein Is Translated from Spliced E6*I Transcripts in High-Risk Human Papillomavirus Type 16- or Type 18-Positive Cervical Cancer Cell Lines via Translation Reinitiation

  2006cited by this paper
• T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx

  2006cited by this paper
• CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients.

  2005cited by this paper
• Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.

  2005cited by this paper
• Effect of Human Papillomavirus-16 Infection on CD8+ T-Cell Recognition of a Wild-Type Sequence p53264–272 Peptide in Patients with Squamous Cell Carcinoma of the Head and Neck

  2004cited by this paper
• Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6

  2004cited by this paper
• Detection of high‐risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT‐polymerase chain reaction

  2004cited by this paper
• Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia.

  2003cited by this paper
• High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.

  2002cited by this paper
• Improved Amplification of Genital Human Papillomaviruses

  2000cited by this paper
• Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions

  2000cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis.

  1998cited by this paper
• Jama: the Journal of the American Medical Association

  year unknowncited by this paper

• From Radiation to Immune Response: A Systematic Review of Systemic Immunomodulation in Squamous Cell Head and Neck Cancer.

  2026cites this paper
• Patient experience and shared decision-making in HPV-positive oropharyngeal cancer: A systematic review of qualitative and quantitative evidence

  2025cites this paper
• Reliable RNA-seq analysis from FFPE specimens as a means to accelerate cancer-related health disparities research

  2024cites this paper
• The Role of the p16 and p53 Tumor Suppressor Proteins and Viral HPV16 E6 and E7 Oncoproteins in the Assessment of Survival in Patients with Head and Neck Cancers Associated with Human Papillomavirus Infections

  2023cites this paper
• Retifanlimab and Other Immune Checkpoint Inhibitors for Squamous Cell Anal Carcinoma

  2023cites this paper
• The crossroads: divergent roles of virus‐specific CD4+ T lymphocytes in determining the outcome for human papillomavirus infection

  2023cites this paper
• Correlation between vaginal flora and cervical immune function of human papilloma virus-infected patients with cervical cancer

  2023cites this paper
• The Tumor-Specific Immune Landscape in HPV+ Head and Neck Cancer

  2023cites this paper
• Integrative genomic analysis reveals low T-cell infiltration as the primary feature of tobacco use in HPV-positive oropharyngeal cancer

  2022cites this paper
• Absolute Lymphocyte Count in Cervical Cancer Patients Prior to Definitive Chemoradiotherapy: a Prognostic Indicator?

  2022cites this paper
• Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender

  2022cites this paper
• Fluid Biomarkers in HPV and Non-HPV Related Oropharyngeal Carcinomas: From Diagnosis and Monitoring to Prognostication—A Systematic Review

  2022cites this paper
• Spontaneous regression of an human papillomavirus‐positive oropharyngeal squamous cell carcinoma

  2022cites this paper
• The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors

  2022cites this paper
• Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination

  2022cites this paper
• HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management

  2022cites this paper
• Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood

  2021cites this paper
• Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy

  2021cites this paper
• Prognostic Significance of CD4+ and CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

  2021cites this paper
• Comparative Multiomic Analysis Reveals Low T Cell Infiltration as the Primary Feature of Tobacco Use in HPV(+) Oropharyngeal Cancer

  2021cites this paper
• Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic

  2021cites this paper
• Human Immunodeficiency Virus Infection Promotes Human Papillomavirus-Mediated Anal Squamous Carcinogenesis: An Immunologic and Pathobiologic Review

  2021cites this paper
• The tumor immune microenvironments of HPV+ and HPV- head and neck cancers.

  2021cites this paper
• Novel Antigenic Targets of HPV Therapeutic Vaccines

  2021cites this paper
• Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.

  2021cites this paper
• Anti-Telomerase CD4+ Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials

  2020cites this paper
• Profiling HPV-16–specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients

  2020cites this paper
• Rate of locoregional recurrence among patients with oropharyngeal squamous cell carcinoma with known HPV status: a systematic review

  2020cites this paper
• Lactate induces PD-L1 in HRASG12V-positive oropharyngeal squamous cell carcinoma

  2020cites this paper
• HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas

  2020cites this paper
• A Phase I trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6/E7 oncogenes after chemoradiation for cervical cancer.

  2020cites this paper
• Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy.

  2019cites this paper
• Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity

  2019cites this paper
• The role of the innate and adaptive immune response in HPV‐associated oropharyngeal squamous cell carcinoma

  2019cites this paper
• [Predictive assays for responses of tumors and normal tissues in radiation oncology].

  2019cites this paper
• The Double-Edged Sword—How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer

  2019cites this paper
• Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer.

  2018cites this paper
• The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy

  2018cites this paper
• Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis.

  2018cites this paper
• Integration of Oncogenes via Sleeping Beauty as a Mouse Model of HPV16+ Oral Tumors and Immunologic Control

  2018cites this paper
• The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy.

  2017cites this paper
• Herpes Simplex Virus Glycoprotein D Targets a Specific Dendritic Cell Subset and Improves the Performance of Vaccines to Human Papillomavirus-Associated Tumors

  2017cites this paper